Condition: Atrial Fibrillation, Paroxysmal or Persistent · Sponsor: University Hospital Ostrava
Secretoneurin (SN) is a neuropeptide from the chromogranin family that influences intracellular calcium handling. SN suppresses calcium leakage from the sarcoplasmic reticulum through the ryanodine receptor. SN is a novel biomarker that has shown the potential to predict adverse arrhythmic events.
This description comes directly from the study's public registry record.
Jiří Hynčica · 0042059737 · jiri.hyncica@fno.cz
Always discuss trial participation with your own doctor first.
| University Hospital Ostrava | Ostrava, Moravian-Silesian Region, Czechia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05794464